Association of blood groups with hepatitis C. viremia

Abstract EN

Hepatitis C virus remained a public health problem with approximately half of the patients untreated and undiagnosed.

Chronic HCV is a leading cause of cirrhosis, fibrosis, hepatocellular carcinoma and other hepatic morbidities.

Active HCV has a prevalence rate of about 1% (71 million).

By July, 2019, 10 million population of Pakistan was declared to have active HCV infection.

According to World Health Organization, 23,720 people died of hepatitis-related complexities in Pakistan in 2016.

Individuals with certain types of ABO blood groups were more susceptible to diverse kinds of infections.

For instance, blood types A and AB predisposed individuals to severe malaria, while type O conferred resistance to the many of the protozoan agent.

This study was designed to explore the association of hepatitis C viremia to blood groups, Rh factors, age and gender distribution among Pakistani population.

Total 246 participants were screened for HCV in Taqwa diagnostics laboratory, Multan and 200 were found positive.

They were divided into 4 groups on the basis of their age.

First group included patients ranging from 17 to 25 (52), second, third and fourth group included patients from 26 to 34 (92), 35 to 43 (42) and 44 to above (14) respectively.

Confirmed Hepatitis C patients were subjected to analysis of blood group, Rh factor and viral load.

Results demonstrated that patients having 'O' blood group (60.37%) were reported for high viral load than any of the other blood groups in the patients of Southern Punjab, Pakistan.

Furthermore, Rh-negative factor (26.42) was associated with high viral load than that of the Rh-positive factor (73.58).

Disclosure practiced that age group (26-34) was reported for the high viral load than that of the any other group of this study.

Females were more aggressively affected by HCV Viremia than male because the mean viral load among the females was higher than that of the males.

Greater social awareness and gender-sensitive healthcare is necessary to improve the experiences of patients with HCV.